Intravenous ibuprofen in postoperative pain and fever management in adults: A systematic review and meta‐analysis of randomized controlled trials
Pharmacology Research & Perspectives · 2023-08 · 11 (4)
DOI: 10.1002/prp2.1123 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 02.08.2023. Verfasst von Pengxiang Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Ibuprofen, Antipyretics. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
This study aims to evaluate the efficacy and safety of multiple or single‐dosage intravenous ibuprofen (IVIB) in managing postoperative pain and fever in adults who are unable to take oral medications. A systematic review and meta‐analysis was conducted based on randomized controlled trials (RCTs) comparing IVIB with placebo or other analgesic and antipyretic medications for postoperative pain and fever management. Data were collected from 8 main databases from the inception to June 2022. Risk of bias assessment was performed, and the GRADE methodology was used to assess the certainty of pooled evidence. Primary outcomes included visual analogue scale (VAS) scores within 24 h postoperative and reduction of temperature. Meta‐analyses were conducted to calculate the mean difference (MD) or risk ratios (RR) and 95% CIs. As a result, a total of twenty‐three RCTs with 3716 participants were included. For postoperative pain, with moderate‐to‐low certainty evidence, IVIB was associated with lower postoperative VAS scores than placebo, with MD ranging from −3.53 (95% CI, −4.32 to −2.75) at 0 min to −0.96 (95% CI, −1.35 to −0.57) at 24 h. Compared with intravenous acetaminophen, IVIB demonstrated lower VAS scores (MD, −1.54 at 0 min; −0.36 at 24 h). For fever, IVIB showed satisfactory antipyretic efficiency in a short period of time, but no difference was observed between IVIB and intravenous acetaminophen. IVIB was well‐tolerated for both pain and fever management. In conclusion, moderate‐to‐low certainty evidence supports the use of IVIB for adults with postoperative pain and fever who are unable to take oral medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Peking University Third Hospital, Beijing, China.
- Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
- Department of Pharmacy, Yantai Yuhuangding Hospital, Shandong, China.
- Department of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
- Department of Pharmacy, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
- Department of Pharmacy, Tianjin Nankai Hospital, Tianjin, China.
ORCID-Profile: Pengxiang Zhou, Lu Chen, Ente Wang, Lanzhi He, Shuxia Tian, Suodi Zhai
Zitieren
APA
Zhou, P., Chen, L., Wang, E., He, L., Tian, S., & Zhai, S. (2023). Intravenous ibuprofen in postoperative pain and fever management in adults: A systematic review and meta‐analysis of randomized controlled trials. Pharmacology Research & Perspectives, 11(4). https://doi.org/10.1002/prp2.1123
Vancouver
Zhou P, Chen L, Wang E, He L, Tian S, Zhai S. Intravenous ibuprofen in postoperative pain and fever management in adults: A systematic review and meta‐analysis of randomized controlled trials. Pharmacology Research & Perspectives. 2023;11(4). doi:10.1002/prp2.1123
BibTeX
@article{Zhou2023,
author = {Zhou, Pengxiang and Chen, Lu and Wang, Ente and He, Lanzhi and Tian, Shuxia and Zhai, Suodi},
title = {Intravenous ibuprofen in postoperative pain and fever management in adults: A systematic review and meta‐analysis of randomized controlled trials},
journal = {Pharmacology Research & Perspectives},
year = {2023},
volume = {11},
number = {4},
doi = {10.1002/prp2.1123}
}
EUVIMED